Tmall vendors to halt drug sales online
Updated: 2016-08-01 13:47
A logo of Tmall.com seen on a street in Beijing, June 1, 2016. [Photo/IC]
A notice on the website of the China Food and Drug Administration (CFDA) urged the halt of drug sales via third-party platforms. CFDA said it sent directives to branches in Hebei, Shanghai, and Guangdong, to stop the drug sales on marketplace websites.
Tmall said its decision was based on the requirement from the CDFA's Hebei province branch.
CFDA said the halt was due to management loopholes it had found, such as the lack of clearly defined accountability between third-party platforms and pharmacies, and difficulties to supervise the prescription drug and ensure quality.
It also said the decision will not affect pharmacies or drugmakers who were licensed to directly sell to costumers online.
Tmall.com launched its online drugstore in 2011 and later bought a medicinal information platform. The B2C platform of Alibaba provided information about medicines and medical equipment too.
- From hunting wild fruits to satellite dishes: Life of Myanmar returnees
- World's first panda-themed subway line runs in Chengdu
- Minister: PLA to firmly protect maritime rights
- China raises alert level ahead of Typhoon Nida
- Japanese suspect detained in security inquiry
- Xi: Disaster relief must be improved
- Powerful blast rocks Afghan capital amid darkness
- Tokyo elects 1st female governor
- 450th Old Bridge diving competition held in Mostar
- S. Korea to launch WWII 'comfort women' victims foundation
- China to become Australia's biggest tourist source market
- Patient shoots, kills doctor in Berlin then kills himself